{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:20:29Z","timestamp":1787242829568,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00259-018-4128-7","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T04:10:32Z","timestamp":1535083832000},"page":"855-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["18F-FDG PET\/CT as a prognostic factor in penile cancer"],"prefix":"10.1007","volume":"46","author":[{"given":"Andr\u00e9","family":"Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Paulino","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Guilherme O.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Silva-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna A.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5818-0954","authenticated-orcid":false,"given":"Marcelo","family":"Mamede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"4128_CR1","unstructured":"American Cancer Society. 2018. \n                    http:\/\/www.cancer.org\/cancer\/penilecancer\/detailedguide\/penile-cancer-key-statistics\n                    \n                  . Accessed in 08\/01\/18."},{"key":"4128_CR2","unstructured":"Instituto Nacional do C\u00e2ncer. 2018. \n                    http:\/\/www2.inca.gov.br\/wps\/wcm\/connect\/tiposdecancer\/\n                    \n                   site\/home\/penis. Accessed in 08\/01\/18."},{"key":"4128_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark PE. National Comprehensive Cancer Network. Penile cancer: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2013;11:594\u2013615.","journal-title":"J Natl Compr Cancer Netw"},{"key":"4128_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2017","unstructured":"Hakenberg OW. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2017;67:142\u201350.","journal-title":"Eur Urol"},{"key":"4128_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00345-008-0288-6","volume":"27","author":"B Hughes","year":"2009","unstructured":"Hughes B. Noninvasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol. 2009;27:197\u2013203.","journal-title":"World J Urol"},{"key":"4128_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.juro.2010.03.145","volume":"184","author":"Y Zhu","year":"2010","unstructured":"Zhu Y. Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol. 2010;184:539\u2013345.","journal-title":"J Urol"},{"key":"4128_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.eururo.2007.02.045","volume":"52","author":"E Wespes","year":"2007","unstructured":"Wespes E. The management of regional lymph nodes in patients with penile carcinoma and reliability of sentinel node biopsy. Eur Urol. 2007;52:15\u20136.","journal-title":"Eur Urol"},{"key":"4128_CR8","first-page":"1","volume":"10","author":"S Gupta","year":"2016","unstructured":"Gupta S. Emerging systemic therapies for the Management of Penile Cancer. Urol Clin N Am. 2016;10:1\u201311.","journal-title":"Urol Clin N Am"},{"key":"4128_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"231","author":"EM Rohren","year":"2004","unstructured":"Rohren EM. Clinical applications of PET in oncology. Radiology. 2004;231:305\u201332.","journal-title":"Radiology"},{"key":"4128_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/114.1.89","volume":"114","author":"MM Ter-Pogossian","year":"1975","unstructured":"Ter-Pogossian MM. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114:89\u201398.","journal-title":"Radiology"},{"key":"4128_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.21873\/anticanres.11393","volume":"37","author":"G Toyokawa","year":"2017","unstructured":"Toyokawa G. Elevated metabolic activity on 18F-FDG PET\/CT is associated with the expression of EZH2 in non-small cell lung ca. Anticancer Res. 2017;37:1393\u2013402.","journal-title":"Anticancer Res"},{"issue":"3","key":"4128_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.oooo.2015.10.018","volume":"121","author":"M Shimizu","year":"2016","unstructured":"Shimizu M. Prognostic value of 2-[(18) F]fluoro-2-deoxy-d-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(3):239\u201347.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4128_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/COC.0b013e31803993f8","volume":"30","author":"M Mamede","year":"2007","unstructured":"Mamede M. FDG-PET\/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol. 2007;30:377\u201388.","journal-title":"Am J Clin Oncol"},{"key":"4128_CR14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0022-5347(05)66372-0","volume":"165","author":"G Ravizzini","year":"2001","unstructured":"Ravizzini G. Positron emission tomography detection of metastatic penile squamous cell carcinoma. J Urol. 2001;165:1633\u20134.","journal-title":"J Urol"},{"key":"4128_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.urolonc.2009.10.012","volume":"30","author":"B Schlenker","year":"2012","unstructured":"Schlenker B. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET\/CT: a prospective single-center study. Urol Oncol. 2012;30:55\u20139.","journal-title":"Urol Oncol"},{"key":"4128_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.21873\/anticanres.11444","volume":"37","author":"C Henkenberens","year":"2017","unstructured":"Henkenberens C. 68Ga-PSMA ligand PET\/CT-based radiotherapy for lymph node relapse of prostate Cancer after primary therapy delays initiation of systemic therapy. Anticancer Res. 2017;37:1273\u201380.","journal-title":"Anticancer Res"},{"issue":"5","key":"4128_CR17","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/RLU.0000000000001578","volume":"42","author":"E Mena","year":"2017","unstructured":"Mena E. Value of Intratumoral metabolic heterogeneity and quantitative 18F-FDG PET\/CT parameters to predict prognosis in patients with HPV-positive primary oropharyngeal squamous cell carcinoma. Clin Nucl Med. 2017;42(5):e227\u201334.","journal-title":"Clin Nucl Med"},{"key":"4128_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2165\/00003088-199426040-00005","volume":"26","author":"DJ Morgan","year":"1994","unstructured":"Morgan DJ. Lean body mass as a predictor of drug dosage: implications for drug therapy. Clin Pharmacokinet. 1994;26:292\u2013307.","journal-title":"Clin Pharmacokinet"},{"key":"4128_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1148\/radiology.213.2.r99nv37521","volume":"213","author":"Y Sugawara","year":"1999","unstructured":"Sugawara Y. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology. 1999;213:521\u20135.","journal-title":"Radiology"},{"key":"4128_CR20","first-page":"259","volume-title":"WHO classification of tumours of the urinary system and male genital organs","author":"H Moch","year":"2016","unstructured":"Moch H. Tumours of the penis. In: WHO classification of tumours of the urinary system and male genital organs. Lyon: IARC; 2016. p. 259\u201385."},{"key":"4128_CR21","first-page":"336","volume-title":"TNM classification of malignant Tumours. UICC International Union against Cancer","author":"LH Sobin","year":"2009","unstructured":"Sobin LH. TNM classification of malignant Tumours. UICC International Union against Cancer. 7th ed. Hoboken: Wiley-Blackwell; 2009. p. 336.","edition":"7"},{"key":"4128_CR22","first-page":"1460","volume":"46","author":"B Scher","year":"2005","unstructured":"Scher B, et al. 18F-FDG PET\/CT for staging of penile cancer. J Nucl Med. 2005;46:1460\u20135.","journal-title":"J Nucl Med"},{"key":"4128_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.6004\/jnccn.2013.0076","volume":"11","author":"PE Spiess","year":"2013","unstructured":"Spiess PE. Current concepts in penile cancer. J Natl Compr Cancer Netw. 2013;11:617\u201324.","journal-title":"J Natl Compr Cancer Netw"},{"key":"4128_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.urology.2011.08.006","volume":"78","author":"J Li","year":"2011","unstructured":"Li J. Organ-sparing surgery for penile cancer: complications and outcomes. Urology. 2011;78:1121\u20134.","journal-title":"Urology"},{"key":"4128_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2016.01.003","volume":"90","author":"G Bozzini","year":"2016","unstructured":"Bozzini G. Role of penile doppler US in the preoperative assessment of penile squamous cell carcinoma patients: results from a large prospective multicenter European study. Urology. 2016;90:131\u20135.","journal-title":"Urology"},{"key":"4128_CR26","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.juro.2008.06.028","volume":"180","author":"AA Ornellas","year":"2008","unstructured":"Ornellas AA. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol. 2008;180:1354\u20139.","journal-title":"J Urol"},{"issue":"7","key":"4128_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/PAS.0b013e31819d17eb","volume":"33","author":"A Chaux","year":"2009","unstructured":"Chaux A. The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol. 2009;33(7):1049\u201357.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4128_CR28","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","volume":"32","author":"EF Velazquez","year":"2008","unstructured":"Velazquez EF. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008;32(7):974\u20139.","journal-title":"Am J Surg Pathol"},{"key":"4128_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00345-008-0315-7","volume":"27","author":"AL Cubilla","year":"2009","unstructured":"Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol. 2009;27:166\u20139.","journal-title":"World J Urol"},{"key":"4128_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.juro.2011.10.033","volume":"187","author":"I Souillac","year":"2012","unstructured":"Souillac I. Prospective evaluation of 18F-FDG PET\/CT to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis. J Urol. 2012;187:493\u20137.","journal-title":"J Urol"},{"key":"4128_CR31","first-page":"1","volume":"28","author":"JK Jakobsen","year":"2015","unstructured":"Jakobsen JK. DaPeCa-3: promising results of sentinel node biopsy combined with 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark. BJU Int. 2015;28:1\u201310.","journal-title":"BJU Int"},{"key":"4128_CR32","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","volume":"18","author":"HL Westreenen Van","year":"2004","unstructured":"Van Westreenen HL. Systematic review of the staging performance of FDG PET in esophageal cancer. J Clin Oncol. 2004;18:3805\u201312.","journal-title":"J Clin Oncol"},{"key":"4128_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","volume":"37","author":"R Sadeghi","year":"2012","unstructured":"Sadeghi R. Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med. 2012;37:436\u201341.","journal-title":"Clin Nucl Med"},{"key":"4128_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fphar.2016.00487","volume":"7","author":"C Buonerba","year":"2016","unstructured":"Buonerba C. Prognostic and predictive factors in patients with advanced penile cancer receiving salvage (2nd or later line) systemic treatment: a retrospective, multi-center study. Front Pharm. 2016;7:487.","journal-title":"Front Pharm"},{"issue":"5","key":"4128_CR35","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1097\/RLU.0000000000001612","volume":"42","author":"SH Hwang","year":"2017","unstructured":"Hwang SH. Prognostic value of pretreatment metabolic tumor volume and total lesion glycolysis using 18F-FDG PET\/CT in patients with metastatic renal cell carcinoma treated with anti\u2013vascular endothelial growth factor\u2013targeted agents. Clin Nucl Med. 2017;42(5):e235\u201341.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"4128_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ijrobp.2011.10.022","volume":"83","author":"KP Chu","year":"2012","unstructured":"Chu KP. Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes. Int J Radiat Oncol Biol Phys. 2012;83(5):1521\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4128-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4128-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4128-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T03:14:35Z","timestamp":1566875675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4128-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4128"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4128-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest. All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}